✦ LIBER ✦

Detection and clinical relevance of anti-DNA/anti-ENA antibodies

✍ Scribed by A.C. Horsfall

Publisher: Elsevier Science
Year: 1988
Tongue: English
Weight: 304 KB
Volume: 9
Category: Article
ISSN: 0167-5699
DOI: 10.1016/0167-5699(88)91285-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical relevance of anti-phospholipid

Clinical relevance of anti-phospholipid antibody tests in childhood

✍ Tamás Constantin; Andrea Ponyi; György Fekete 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 125 KB

Detection of anti-double and anti-single

Detection of anti-double and anti-single stranded DNA antibodies in chronic liver disease: Significance of anti-double stranded DNA antibody in autoimmune hepatitis

✍ Kimiaki Tsuchiya; Kendo Kiyosawa; Haruhiko Imai; Takeshi Sodeyama; Seiichi Furut 📂 Article 📅 1994 🏛 Springer Japan 🌐 English ⚖ 561 KB

Anti AChR antibody: Relevance to diagnos

Anti AChR antibody: Relevance to diagnosis and clinical aspects of myasthenia gravis

✍ R. Mantegazza; D. Pareyson; F. Baggi; P. Romagnoli; D. Peluchetti; A. Sghirlanzo 📂 Article 📅 1988 🏛 Springer Milan 🌐 English ⚖ 336 KB

Clinical relevance of non-neuronal auto-

Clinical relevance of non-neuronal auto-antibodies in patients with anti-Hu or anti-Yo paraneoplastic diseases

✍ Lucinda Aguirre-Cruz; Jean-Luc Charuel; Antoine F. Carpentier; Baya Benyahia; Je 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 74 KB

Detection of low avidity anti-dna antibo

Detection of low avidity anti-dna antibodies in systemic lupus erythematosus

✍ Richard L. Riley; Hugh Mcgrath Jr.; Ronald P. Taylor 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 616 KB

CLINICAL SIGNIFICANCE OF ANTI–DOUBLE-STR

CLINICAL SIGNIFICANCE OF ANTI–DOUBLE-STRANDED DNA ANTIBODIES DETECTED BY A SOLID PHASE ENZYME IMMUNOASSAY

✍ Thomas E. Miller; Robert G. Lahita; Vincent J. Zarro; Joanne Macwilliam; David K 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 752 KB

## Abstract A solid phase enzyme immunoassay (EIA) detected anti‐double‐stranded (ds) DNA antibodies in 88% of sera from patients classified clinically as having active systemic lupus erythematosus (SLE) without renal symptoms and 93% with renal disease. Fifty‐six percent of sera from patients with